Explain this page
Arphra AIPlain-English read on MiniMed Group, Inc. Common Stock’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $19.00 (+26.67%)
Candlestick · 1Y
Open in chart workstation →MMED
15.16-18.01%H 20.48L 10.65MA50 —MA200 —Avg vol 1.1M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.06% | -1.19% | +38.89% | -4.82% | -18.88% | -18.88% | -18.88% | -18.88% | -18.88% | -18.88% | -18.88% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$14.70
Bid
$14.00
10 sh
Ask
$15.77
250 sh
Spread
$1.770
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Financial Services+1.26%
- Utilities+0.83%
- Communication Services+0.46%
- Energy+0.45%
- Technology+0.34%
- Consumer Defensive-0.21%
- Industrials-0.32%
- Healthcare-0.39%
- Real Estate-0.67%
- Consumer Cyclical-0.94%
- Basic Materials-1.06%
Top industries (issuer's industry highlighted)
No industry data returned.
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- MiniMed Group Q4 Earnings Call Highlightsmarketbeat.com·Jun 03, 2026
- MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbottprnewswire.com·Jun 03, 2026
- MiniMed Delivers Strong Fourth Quarter and Full Fiscal Year 2026 Financial Results; Provides Fiscal Year 2027 Outlookprnewswire.com·Jun 03, 2026
Recent analyst activity
DB- Jun 04, 2026GradeBuy → BuyBenchmark Reiterates Buy Rating on MiniMed Group (MMED) Following Better-Than-Expected Q4Benchmark
- Jun 04, 2026GradeNeutral → NeutralPiper Sandler on MiniMed Group (MMED): 'Nice Start as a Public Entity but Still Plenty to Prove'Piper Sandler
- Jun 04, 2026PT$16.00Piper Sandler on MiniMed Group (MMED): 'Nice Start as a Public Entity but Still Plenty to Prove'Piper Sandler
- Jun 04, 2026GradeOverweight → OverweightMiniMed price target lowered to $22 from $26 at Wells FargoWells Fargo
- Jun 04, 2026PT$22.00MiniMed price target lowered to $22 from $26 at Wells FargoWells Fargo
Peers
No peer list available for MMED.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|